Charles Schwab Investment Management Inc Ocugen, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 170,254 shares of OCGN stock, worth $274,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170,254
Previous 170,254
-0.0%
Holding current value
$274,108
Previous $97,000
187.63%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding OCGN
# of Institutions
88Shares Held
32.8MCall Options Held
518KPut Options Held
345K-
Vanguard Group Inc Valley Forge, PA12MShares$19.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.8MShares$6.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$5.17 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$4.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.93MShares$3.1 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $349M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...